[Radiosurgery of benign intracranial lesions. Indications, results , and perspectives].
Authors
Danthez N,De Cournuaud C,Pistocchi S,Aureli V,Giammattei L,Hottinger AF,Schiappacasse L
Affiliations (5)
Affiliations (5)
- Service de radio-oncologie, Département d'oncologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
- Centre de recherche Famille Lundin sur les tumeurs cérébrales, Centre hospitalier universitaire vaudois, 1011 Lausanne.
- Service de radiodiagnostic et radiologie interventionnelle, Département de radiologie médicale, Centre hospitalier universitaire vaudois, 1011 Lausanne.
- Service de neurochirurgie, Département des neurosciences cliniques, Centre hospitalier universitaire vaudois, 1011 Lausanne.
- Service d'oncologie médicale, Département d'oncologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract
Stereotactic radiosurgery (SRS) is a non-invasive technique that is transforming the management of benign intracranial lesions through its precision and preservation of healthy tissues. It is effective for meningiomas, trigeminal neuralgia (TN), pituitary adenomas, vestibular schwannomas, and arteriovenous malformations. SRS ensures high tumor control rates, particularly for Grade I meningiomas and vestibular schwannomas. For refractory TN, it provides initial pain relief > 80 %. The advent of technologies such as PET-MRI, hypofractionation, and artificial intelligence is further improving treatment precision, but challenges remain, including the management of late side effects and standardization of practice.
Topics
RadiosurgeryBrain NeoplasmsEnglish AbstractJournal Article